Itolizumab Current Affairs, GK & News

What is Emergency Use Authorization?

Recently, several drug makers are seeking Emergency Use Authorisation (EUA) for the COVID-19 vaccine. Pfizer had applied for the EUA in UK and has been approved by the Medicines and Healthcare Products Regulatory Agency of the country. Also, the Serum Institute of India and Moderna have also applied for the Emergency Use Authorisation of COVID-19 ..

Month: 

Category: 

Topics: 

DCGI allows use of “Itolizumab” for moderate to severe COVID-19 cases

On July 11, 2020, the Dugs Controller General of India (DCGI) granted restricted emergency use of Itolizumab for moderate to severe COVI-19 patients. Highlights Itolizumab is a monoclonal antibody that was already approved for chronic plaque psoriasis. The drug will now be used to treat COVID-19 based on clinical trials. The drug was manufactured and ..

Month: 

Category: 

Topics: